Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart

In the zebrafish (Danio rerio), regeneration and fibrosis after cardiac injury are not mutually exclusive responses. Upon cardiac cryoinjury, collagen and other extracellular matrix (ECM) proteins accumulate at the injury site. However, in contrast to the situation in mammals, fibrosis is transient...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 115; no. 16; pp. 4188 - 4193
Main Authors Sánchez-Iranzo, Héctor, Galardi-Castilla, María, Sanz-Morejón, Andrés, González-Rosa, Juan Manuel, Costa, Ricardo, Ernst, Alexander, de Aja, Julio Sainz, Langa, Xavier, Mercader, Nadia
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 17.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the zebrafish (Danio rerio), regeneration and fibrosis after cardiac injury are not mutually exclusive responses. Upon cardiac cryoinjury, collagen and other extracellular matrix (ECM) proteins accumulate at the injury site. However, in contrast to the situation in mammals, fibrosis is transient in zebrafish and its regression is concomitant with regrowth of the myocardial wall. Little is known about the cells producing this fibrotic tissue or how it resolves. Using novel genetic tools to mark periostin b- and collagen 1alpha2 (col1a2)-expressing cells in combination with transcriptome analysis, we explored the sources of activated fibroblasts and traced their fate. We describe that during fibrosis regression, fibroblasts are not fully eliminated but become inactivated. Unexpectedly, limiting the fibrotic response by genetic ablation of col1a2-expressing cells impaired cardiomyocyte proliferation. We conclude that ECM-producing cells are key players in the regenerative process and suggest that antifibrotic therapies might be less efficient than strategies targeting fibroblast inactivation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
1Present address: Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
Edited by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved March 12, 2018 (received for review September 26, 2017)
Author contributions: H.S.-I. and N.M. designed research; H.S.-I., M.G.-C., A.S.-M., R.C., A.E., and J.L. performed research; H.S.-I., J.M.G.-R., and J.S.d.A. contributed new reagents/analytic tools; H.S.-I., A.S.-M., and N.M. analyzed data; and H.S.-I., M.G.-C., A.S.-M., and N.M. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1716713115